Silvaco Group (NASDAQ: SVCO) insider transactions
In the twelve months to 10 November 2026, executives and directors of Silvaco Group reported 20 open-market sales of 1,374,023 shares ($5.0m) and 11 open-market purchases of 106,622 shares ($446,999), by 9 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 November 2026 | Ngai Anthony K.K. | Director | Grant or award | +2,540 | — | 121,512 | Form 4 |
| 9 November 2026 | Ganti Anita | Director | Grant or award | +2,149 | — | 66,683 | Form 4 |
| 9 November 2026 | Pesic Illiya I. | Director | Grant or award | +1,758 | — | 5,397,839 | Form 4 |
| 9 November 2026 | Ngai-Pesic Katherine S. | Director | Grant or award | +3,126 | — | 9,182,033 | Form 4 |
| 9 November 2026 | Jackson Candace | See Remarks | Open-market sale | −1,557 | $7.05 | 44,722 | Form 4 |
| 9 November 2026 | Zegarelli Christopher John | Chief Financial Officer | Open-market sale | −39,662 | $7.05 | 500,662 | Form 4 |
| 9 November 2026 | Bo-Linn Cheemin | Director | Grant or award, 10b5-1 plan | +2,344 | — | 20,608 | Form 4 |
| 9 November 2026 | Bo-Linn Cheemin | Director | Open-market sale, 10b5-1 plan | −1,172 | $7.32 | 19,436 | Form 4 |
| 9 November 2026 | Tewksbury Ted L III | Director | Grant or award, 10b5-1 plan | +1,954 | — | 20,097 | Form 4 |
| 9 November 2026 | Tewksbury Ted L III | Director | Open-market sale, 10b5-1 plan | −977 | $7.31 | 19,120 | Form 4 |
| 29 August 2026 | Rhines Walden C | Chief Executive Officer | Grant or award | +250,376 | — | 539,209 | Form 4 |
| 25 August 2026 | Jackson Candace | See Remarks | Open-market sale | −3,500 | $7.00 | 46,279 | Form 4 |
| 12 August 2026 | Jackson Candace | See Remarks | Open-market sale | −1,570 | $7.55 | 49,779 | Form 4 |
| 12 August 2026 | Zegarelli Christopher John | Chief Financial Officer | Open-market sale | −2,257 | $7.55 | 540,324 | Form 4 |
| 11 August 2026 | Pesic Illiya I. | Director | Grant or award | +1,409 | — | 5,396,081 | Form 4 |
| 11 August 2026 | Bo-Linn Cheemin | Director | Grant or award, 10b5-1 plan | +1,400 | — | 18,964 | Form 4 |
| 11 August 2026 | Bo-Linn Cheemin | Director | Open-market sale, 10b5-1 plan | −700 | $7.28 | 18,264 | Form 4 |
| 11 August 2026 | Tewksbury Ted L III | Director | Grant or award, 10b5-1 plan | +1,159 | — | 18,723 | Form 4 |
| 11 August 2026 | Tewksbury Ted L III | Director | Open-market sale, 10b5-1 plan | −580 | $7.28 | 18,143 | Form 4 |
| 11 August 2026 | Ganti Anita | Director | Grant or award | +1,721 | — | 64,534 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Silvaco Group page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.